Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury. [electronic resource]
Producer: 20161031Description: 405-10 p. digitalISSN:- 1433-2965
- Adult
- Aged
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Bone Remodeling -- drug effects
- Denosumab -- therapeutic use
- Female
- Femur Neck -- drug effects
- Follow-Up Studies
- Hip Joint -- drug effects
- Humans
- Lumbar Vertebrae -- drug effects
- Male
- Middle Aged
- Osteoporosis -- drug therapy
- Spinal Cord Injuries -- complications
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.